One Step Ahead
Rapid Diagnosis, Saves Lives: Detect Colorectal Cancer Early with Genobio!
Who Are We?
Founded in 2023, GenoBio is a research and development company that aims to offer innovative solutions in the field of biotechnology. Our main focus is on developing innovative products for the early diagnosis of diseases by concentrating on genetic analysis and diagnostic technologies.
In this regard, we are working on detecting genetic mutations and enabling the early-stage diagnosis of diseases. Currently, we have diagnostic kits undergoing intensive development to achieve this goal.
GenoBio has a team equipped with an innovative spirit. We believe in the potential of biotechnology to revolutionize health sciences. In the future, we will continue to focus on innovations in the biotechnology sector to develop more new solutions in the field of health.
Vision
Our goal is to create faster, more reliable, and more unique solutions to existing problems in order to improve human life.
Mission
In addition to the healthcare field, we aim to develop innovative products and services to address needs in agriculture, the environment, and other sectors.
Values
Committed to ethical and transparent principles, we are engaged in a constant process of innovation. Through teamwork, we are determined to use our strengths innovatively and solution-oriented for the betterment of humanity.
Colorectal Cancer (CRC) Genetic Mutation Screening/Diagnostic Kit
The CRC Genetic Mutation Screening/Diagnostic Kit is developed by GenoBio Biotechnology to support personalized cancer treatment. Its specially designed LNA-based approach offers an extremely sensitive method for the detection of low levels of cfDNA using minimally invasive or non-invasive methods
